Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Contribution of natural killer cells in innate immunity against colorectal cancer. | Front Oncol | 2022 | 36686835 | PubTator, text mining | PubMed |
| Construction and validation of a prognostic model for hepatocellular carcinoma: Inflammatory ferroptosis and mitochondrial metabolism indicate a poor prognosis. | Front Oncol | 2022 | 36686830 | PubTator, text mining | PubMed |
| Is CD19-directed chimeric antigen receptor T cell therapy a smart strategy to combat central nervous system lymphoma? | Front Oncol | 2022 | 36686821 | PubTator, text mining | PubMed |
| Construction of a ferroptosis scoring system and identification of LINC01572 as a novel ferroptosis suppressor in lung adenocarcinoma. | Front Pharmacol | 2022 | 36686701 | PubTator, text mining | PubMed |
| Development of a novel pyroptosis-related LncRNA signature with multiple significance in acute myeloid leukemia. | Front Genet | 2022 | 36685973 | PubTator, text mining | PubMed |
| Discovery and Validation of a SIT1-Related Prognostic Signature Associated with Immune Infiltration in Cutaneous Melanoma. | J Pers Med | 2022 | 36675674 | PubTator, text mining | PubMed |
| Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidences. | Explor Target Antitumor Ther | 2022 | 36654819 | PubTator, text mining | PubMed |
| Immune Checkpoint Inhibitor Therapy in Oncology: Current Uses and Future Directions: JACC: CardioOncology State-of-the-Art Review. | JACC CardioOncol | 2022 | 36636451 | PubTator, text mining | PubMed |
| Atherosclerosis With Immune Checkpoint Inhibitor Therapy: Evidence, Diagnosis, and Management: JACC: CardioOncology State-of-the-Art Review. | JACC CardioOncol | 2022 | 36636438 | PubTator, text mining | PubMed |
| Construction and Validation of a Novel Immune Checkpoint-Related Model in Clear Cell Renal Cell Carcinoma. | Dis Markers | 2022 | 36618968 | PubTator, text mining | PubMed |
| Prediction of prognosis and immunotherapy response of amino acid metabolism genes in acute myeloid leukemia. | Front Nutr | 2022 | 36618700 | PubTator, text mining | PubMed |
| Insights into mucosal associated invariant T cell biology from human inborn errors of immunity. | Front Immunol | 2022 | 36618406 | PubTator, text mining | PubMed |
| Chimeric antigen receptor T-cell therapy for multiple myeloma. | Front Immunol | 2022 | 36618390 | PubTator, text mining | PubMed |
| The Role of Cancer Stem Cells and Their Extracellular Vesicles in the Modulation of the Antitumor Immunity. | Int J Mol Sci | 2022 | 36613838 | PubTator, text mining | PubMed |
| Prognostic and Immunological Implications of FAM72A in Pan-Cancer and Functional Validations. | Int J Mol Sci | 2022 | 36613817 | PubTator, text mining | PubMed |
| Towards Novel Gene and Cell Therapy Approaches for Cervical Cancer. | Cancers (Basel) | 2022 | 36612258 | PubTator, text mining | PubMed |
| Present and Future Role of Immune Targets in Acute Myeloid Leukemia. | Cancers (Basel) | 2022 | 36612249 | PubTator, text mining | PubMed |
| Adoptive Cell Therapy for T-Cell Malignancies. | Cancers (Basel) | 2022 | 36612092 | PubTator, text mining | PubMed |
| TLR9 and Glioma: Friends or Foes? | Cells | 2022 | 36611945 | PubTator, text mining | PubMed |
| NUDT1 Could Be a Prognostic Biomarker and Correlated with Immune Infiltration in Clear Cell Renal Cell Carcinoma. | Appl Bionics Biomech | 2022 | 36606241 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=50